Filing Flows › Nexgel (NXGL) › Q1 2026
Nexgel (NXGL) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 14, 2026
Nexgel (NXGL) reported revenue of $2.6M for the first quarter 2026 (Q1 2026), -6% from a year earlier and -5% from the quarter before. Operating margin was -36.2%, net loss $871K (32.9% of revenue).
Nexgel, Q1 2026: revenue $2.6M (-6% year over year), operating margin -36.2%, net loss $871K, operating cash flow −$504K. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.6M | -5% | -6% |
| Operating profit | −$958K | — | — |
| Net earnings | −$871K | — | — |
| Operating cash flow | −$504K | -279% | — |
What changed
Revenue was $2.6M in Q1 2026, down 6% year over year and down 5% from the previous quarter.
Gross margin was 40.0%, down 2.3 points from Q1 2025. Operating costs exceeded revenue by $1.0M, an operating margin of -36.2%. Operating expenses grew 3% against a revenue fall of 6%. The quarter ended with a net loss of $871K, narrower than the previous quarter's $928K loss.
Operating cash flow was −$504K. Non-cash charges added back $99K of depreciation and amortization and $143K of share-based compensation. Working capital and other items added $125K. Capital expenditures of $9K exceeded it, leaving free cash flow of −$513K.
Questions
What was Nexgel's revenue in the first quarter 2026?
Nexgel (NXGL) reported revenue of $2.6M for the first quarter 2026 (Q1 2026), -6% from a year earlier and -5% from the quarter before.
Was Nexgel profitable in the first quarter 2026?
Operating loss was $958K (-36.2% of revenue) and net loss $871K.
Source: Nexgel 10-Q on SEC EDGAR.